Investigator
Professor · University of California Los Angeles, Bioengineering
Viscoelastic synthetic antigen-presenting cells for augmenting the potency of cancer therapies
The use of synthetic antigen-presenting cells to activate and expand engineered T cells for the treatment of cancers typically results in therapies that are suboptimal in effectiveness and durability. Here we describe a high-throughput microfluidic system for the fabrication of synthetic cells mimicking the viscoelastic and T-cell-activation properties of antigen-presenting cells. Compared with rigid or elastic microspheres, the synthetic viscoelastic T-cell-activating cells (SynVACs) led to substantial enhancements in the expansion of human CD8
Professor
University of California Los Angeles · Bioengineering
University of California Berkeley · Bioengineering
Assistant Resarch Scientist
University of California San Diego · Bioengineering
US
